5 mg
CoA on request
Metabolic Research
Tirzepatide
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
$149
View
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
| Size | 5 mg |
|---|---|
| Form | Lyophilized powder |
| Purity / documentation | Lot-specific Certificate of Analysis available on request |
| CAS | 910463-68-2 |
| Molecular weight | 4113.6 g/mol (reference) |
| Sequence / identity | GLP-1 receptor agonist peptide analog (research material) |
| Intended use | In vitro laboratory research only (RUO) |
Semaglutide research material is intended for laboratory investigation of GLP-1 receptor pathways and metabolic signaling in experimental systems. Not for human use. Use only in qualified research settings with appropriate institutional controls.
Content is for scientific reference only and does not constitute medical advice or instructions for human use.
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.